The expression of TGF-β1 in the early stages of DMD may be critical for initiating muscle fibrosis, and antifibrosis treatment might slow the progression of the disease, increasing the utility of gene therapy [21], [22]. The gene discussed is TGFB1; the disease is Duchenne muscular dystrophy.